We are live on ! Find out more
CT

Cambridge Trust Portfolio holdings

AUM $2.64B
1-Year Est. Return 28.73%
This Fund
S&P 500
This Quarter Est. Return
+10.52%
1 Year Est. Return
+28.73%
3 Year Est. Return
+42.93%
5 Year Est. Return
+123.28%
10 Year Est. Return
+319.22%
AUM
$2.64B
AUM Growth
+$244M
Cap. Flow
+$55.9M
Cap. Flow %
2.11%
Top 10 Hldgs %
30.38%
Holding
727
New
40
Increased
101
Reduced
241
Closed
72

Sector Composition

Rank Sector Weight
1 Technology 23.34%
2 Financials 12.86%
3 Healthcare 10.67%
4 Consumer Discretionary 8.33%
5 Industrials 7.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CERE
726
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
-250
Closed -$10.6K
AFT
727
DELISTED
Apollo Senior Floating Rate Fund Inc.
AFT
-440
Closed -$5.83K

Similar funds

Cambridge Trust's Q1 2024 Portfolio in Review

As of Q1 2024, Cambridge Trust held 727 positions worth $2.64B, up 10% from $2.4B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Cambridge Trust's Q1 2024 filing shows 40 new, 101 increased, 241 reduced and 72 closed positions. Its largest new stake was Best Buy: 93,973 shares worth $7.71M. The largest sale was JPMorgan Equity Premium Income ETF, an estimated $12.2M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.

  • Cambridge Trust's largest Q1 2024 buy was Best Buy: 93,973 shares worth $7.71M.
  • Cambridge Trust added most to iShares MSCI EAFE Growth ETF in Q1 2024, an estimated $38M increase.
  • Cambridge Trust's biggest Q1 2024 reduction was JPMorgan Equity Premium Income ETF, cutting an estimated $12.2M.
  • Cambridge Trust fully exited Marvell Technology in Q1 2024, selling an estimated $302K.
  • Cambridge Trust's ten largest holdings make up 30% of its $2.64B portfolio in Q1 2024.
  • Cambridge Trust opened 40 new positions and closed 72 in Q1 2024.
  • Cambridge Trust's portfolio value rose 10% quarter-over-quarter to $2.64B.

Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.